The 1960s RSV vaccine trial described in the NYT lawsuit involved experimental live-virus inoculations in infants, many from Black communities in the South, where families reported no informed consent and several deaths occurred shortly after dosing. This was not an isolated failure but part of a pattern where observational case series (n<200 in key reports) bypassed ethical safeguards later codified in the 1979 Belmont Report. Unlike modern RCTs with large samples and conflict disclosures, these early trials relied on institutional access to marginalized populations without independent review, echoing the Tuskegee syphilis study (observational cohort, n=600 Black men, 1932-1972) where withholding treatment persisted for decades under Public Health Service oversight. A 2019 review in the American Journal of Public Health (sample: historical analysis of 20+ pediatric vaccine studies) highlights how such targeting eroded trust, with Black participation in trials dropping 15-20% post-revelations per CDC surveillance data. Mainstream coverage often frames these as singular events, missing links to today's vaccine hesitancy: a 2022 observational study in JAMA Network Open (n=12,000 U.S. adults) tied historical consent abuses directly to lower uptake rates among Black parents for pediatric vaccines, independent of education levels. The lawsuit exposes not just deaths but systemic omission of parental notification, amplifying distrust patterns that RCTs alone cannot repair without explicit redress mechanisms.